Article
A single-nucleotide polymorphism in the TP53 and MDM-2 gene modifies breast cancer risk in an ethnic Arab population.
Fundamental & clinical pharmacology - 1 Jun 2012
Alshatwi Ali A, Hasan Tarique N, Shafi Gowhar, Alsaif Mohammed A, Al-Hazzani Amal A, Alsaif Adulaziz A
Abstract excerpt
Breast cancer is the most common oncological disease in women worldwide. Genetic predisposition to breast cancer can be associated with single-nucleotide polymorphisms (SNPs), which are observed in many women. Such gene polymorphisms, in combination with nutritional and environmental factors, can affect breast cancer development. The tumor suppressor TP53 and its negative regulator MDM2 play crucial roles in...
Topics
- Adult
- Arabs
- Breast Neoplasms
- Case-Control Studies
- Ethnicity
- Female
- Genetic Predisposition to Disease
- Humans
- Middle Aged
- Polymorphism, Single Nucleotide
- Proto-Oncogene Proteins c-mdm2
